USA flag logo/image

An Official Website of the United States Government

MULTIPLE DRUG DETECTION IN FINGER PRICK BLOOD

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
16807
Program Year/Program:
1991 / SBIR
Agency Tracking Number:
16807
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
SURMODICS, INC.
SURMODICS, INC. 9924 W 74TH ST EDEN PRAIRIE, MN 55344
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1991
Title: MULTIPLE DRUG DETECTION IN FINGER PRICK BLOOD
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

WE WILL DEVELOP AND DEMONSTRATE THE FEASIBILITY OF AN ENZYMEIMMUNOASSAY FORMAT CAPABLE OF SIMULTANEOUSLY DETECTING AND IDENTIFYING ANY ONE OR MORE OF MULTIPLE DRUGS IN BLOOD FROM A FINGER PRICK. THE EVENTUAL GOAL IS TO DEVELOP A SCREENINGTEST DEVICE HAVING A BUILT-IN SAMPLER WHICH WOULD ALLOW THE USER TO TOUCH THE DEVICE ONTO A DROP OF BLOOD FROM A FINGER PRICK, TURN THE DEVICE OVER AND TAP IT TO INTRODUCE THE SAMPLE, PLACE THE DEVICE INTO A DEVELOPING SOLUTION, WAIT FOR A FEW MINUTES AND OBSERVE THE RESULTS. ANY DESIGNATED BANDS HAVING COLOR WOULD INDICATE THE PRESENCE OF THE CORRESPONDING DRUG. THE SPECIFIC GOAL OF THE PHASE I PROJECT IS TO DEVELOP THE TECHNIQUE, USING A SIMPLER APPARATUS, AND TO DEMONSTRATE THAT ANY COMBINATION OF COCAINE, MORPHINE AND PHENCYCLIDINE CAN BE IDENTIFIED IN A SMALL BLOOD SAMPLE, EACH AT 20 NANOGRAMS/ML OR GREATER CONCENTRATIONS. WE WILL DEVELOP AND DEMONSTRATE THE FEASIBILITY OF AN ENZYMEIMMUNOASSAY FORMAT CAPABLE OF SIMULTANEOUSLY DETECTING AND IDENTIFYING ANY ONE OR MORE OF MULTIPLE DRUGS IN BLOOD FROM A FINGER PRICK. THE EVENTUAL GOAL IS TO DEVELOP A SCREENINGTEST DEVICE HAVING A BUILT-IN SAMPLER WHICH WOULD ALLOW THE USER TO TOUCH THE DEVICE ONTO A DROP OF BLOOD FROM A FINGER PRICK, TURN THE DEVICE OVER AND TAP IT TO INTRODUCE THE SAMPLE, PLACE THE DEVICE INTO A DEVELOPING SOLUTION, WAIT FOR A FEW MINUTES AND OBSERVE THE RESULTS. ANY DESIGNATED BANDS HAVING COLOR WOULD INDICATE THE PRESENCE OF THE CORRESPONDING DRUG. THE SPECIFIC GOAL OF THE PHASE I PROJECT IS TO DEVELOP THE TECHNIQUE, USING A SIMPLER APPARATUS, AND TO DEMONSTRATE THAT ANY COMBINATION OF COCAINE, MORPHINE AND PHENCYCLIDINE CAN BE IDENTIFIED IN A SMALL BLOOD SAMPLE, EACH AT 20 NANOGRAMS/ML OR GREATER CONCENTRATIONS.

Principal Investigator:

Melvin J Swansen
6128292700

Business Contact:

Small Business Information at Submission:

Bio-metric Systems Inc
9924 W 74th St Eden Prairie, MN 55344

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No